Results 231 to 240 of about 75,345 (303)

Nanoagonist‐mediated spatiotemporal reprogramming of macrophage phenotypes to potentiate tumor immunotherapy

open access: yesBMEMat, EarlyView.
This review systematically summarizes the major molecular mechanisms governing TAM polarization and their coordinated interactions. It further highlights recent advances in nanoagonist‐based strategies that intervene in these pathways to reprogram TAMs, critically discussing their therapeutic potential, current limitations, and translational prospects.
Siqi Fang   +7 more
wiley   +1 more source

GMMA as adjuvant and carrier for mucosal delivery of group A streptococcus glycoconjugate vaccine. [PDF]

open access: yesHum Vaccin Immunother
Ozanne J   +10 more
europepmc   +1 more source

Licensed and investigational TLR4 agonists as vaccine adjuvants: structural basis, clinical progress, and future directions. [PDF]

open access: yesFront Immunol
Zhou J   +10 more
europepmc   +1 more source

Programmable Antigen-Specific Immunity via Self-Adjuvanting Nanovaccines Co-Delivering Immune Modulators. [PDF]

open access: yesAngew Chem Int Ed Engl
Ito K   +9 more
europepmc   +1 more source

An Engineered Nano-Vesicle Adjuvant Platform (ENAP) for Cytokine Delivery Enables a Novel Antigen-Coordinated Vaccine Against Helicobacter pylori. [PDF]

open access: yesJ Extracell Vesicles
Shang Y   +14 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Lithium as an immunologic adjuvant

Medical Hypotheses, 1980
Lithium, an adenylate cyclase inhibitor, stimulates a variety of in vitro indices of immune function, including proliferation of lymphocytes in response to mitogens, rosette formation by T-cells and phagocytosis by macrophages. Lithium enhances these immunologic responses at concentrations comparable to those achieved in patients receiving lithium for ...
L, Shenkman, W, Borkowsky, B, Shopsin
openaire   +2 more sources

Home - About - Disclaimer - Privacy